Journal
ONCOLOGIST
Volume 27, Issue 4, Pages 272-284Publisher
OXFORD UNIV PRESS
DOI: 10.1093/oncolo/oyab048
Keywords
cancer; multiomics; genomics; transcriptomics; proteomics; digital pathology; machine learning; artificial intelligence
Categories
Funding
- Indivumed GmbH, Hamburg
Ask authors/readers for more resources
This paper discusses the development and importance of multiomics in clinical practice, highlighting the knowledge gap within the medical community and urging physicians to actively adapt and prepare for this new era.
Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificial intelligence are now commonplace, and this rapid evolution has left us with a significant knowledge gap within the medical community. In this paper, we attempt to bridge that gap and prepare the physician in oncology for multiomics, a group of technologies that have gone from looming on the horizon to become a clinical reality. The era of multiomics is here, and we must prepare ourselves for this exciting new age of cancer medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available